Rice bran phytic acid induced apoptosis through regulation of Bcl-2/Bax and p53 genes in HepG2 human hepatocellular carcinoma cells

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 8, 2014, Pages 3731-3736

  Al Fatlawi, Atheer Abbas ^a,b   Al Fatlawi, Anees Abbas ^b   Irshad, Md ^b   Zafaryab, Md ^b   Moshahid Alam Rizvi, M ^b   Ahmad, Ayaz ^a  

^a NIMS UNIVERSITY   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Antioxidant; Apoptosis; Bax; Bcl 2; Caspases; Cytotoxicity; DNA fragmentation; p53; Phytic acid

Indexed keywords

ANTIOXIDANT; CASPASE 3; CASPASE 9; PHYTIC ACID; PROTEIN BAX;

APOPTOSIS; CELL SURVIVAL; DNA FRAGMENTATION; DRUG EFFECTS; DRUG SCREENING; GENETICS; HEPG2 CELL LINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RICE; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANTIOXIDANTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CASPASE 9; CELL SURVIVAL; DNA FRAGMENTATION; DRUG SCREENING ASSAYS, ANTITUMOR; GENES, BCL-2; GENES, P53; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; ORYZA SATIVA; PHYTIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84901982415     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.8.3731     Document Type: Article

References (46)

1. Ahmad I, Irshad M, Rizvi MMA (2011). Nutritional and medicinal potential of lagenaria siceraria. Int J Veg Sci, 17, 157-70.
2. Alabsi AM, Ali R, Ali AM, et al (2013). Induction of caspase-9, biochemical assessment and morphological changes caused by apoptosis in cancer cells treated with goniothalamin extracted from Goniothalamus macrophyllus. Asian Pac J Cancer Prev, 14, 6273-80.
3. Bode AM, Dong Z (2000). Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Onco, 1, 181-8.
4. Canan C, Cruz FTL, Delaroza F, et al (2011). Studies on the extraction and purification of phytic acid from rice bran. J Food Composition & Analysis, 24, 1057-63.
5. Du P, Cao H, Wu H, et al (2013). Blocking Bcl-2 leads to autophagy activation and cell death of the HEPG2 liver cancer cell line. Asian Pac J Cancer Prev, 14, 5849-54.
6. El-Sherbiny YM, Cox MC, Ismail ZA, et al (2000). G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6). Anticancer Res, 21, 2393-403.
7. Errami Y, Naura AS, Kim H, et al (2013). Apoptotic DNA fragmentation may be a cooperative activity between caspase-activated deoxyribonuclease and the poly (ADP-ribose) polymerase-regulated DNAS1L3, an endoplasmic reticulum-localized endonuclease that translocates to the nucleus during Apoptosis. J Biol Chem, 288, 3460-8.
8. Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008 v1.2, cancer Incidence and mortality worldwide: IARC cancer base no. 10. IARC press, Lyon, France:. available from: http://globocan.iarc.fr.
9. Fox CH, Eberl M (2002). Phytic acid (IP6), novel broad spectrum anti-neoplastic agent: a systematic review. Compl Ther Med, 10, 229-34.
10. Fu D, Richardson DR (2007). Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion. Blood, 110, 752-61.
11. Fulda S, Debatin KM (2006). Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene, 25, 4798-811.
12. Graf E, Eaton JW (1990). Antioxidant functions of phytic acid. Free Radic Bio Med, 8, 61-9.
13. Hassan ZK, Elamin MH, Omer SA, et al (2013). Oleuropein induces apoptosis via the p53 pathway in breast cancer cells. Asian Pac J Cancer Prev, 14, 6739-42.
14. Hatcher HC, Singh RN, Torti FM, et al (2009). Synthetic and natural iron chelators: therapeutic potential and clinical use. Fut med chem, 1, 1643-70.
15. Henderson AJ, Ollila CA, Kumar A, et al (2012). Chemopreventive properties of dietary rice bran: current status and future prospects. Adv Nutr, 3, 643-53.
16. Hurrel, RF (2004). Phytic acid degradation as a means of improving iron absorption. Int J Vitamin & Nutr Res, 74, 445-52.
17. Irshad M, Ahmad I, Mehdi SJ, et al (2014). Antioxidant capacity and phenolic content of the aqueous extract of commonly consumed cucurbits. Int J Food Properties, 17, 179-86.
18. Irshad M, Zafaryab M, Singh M, et al (2012). Comparative analysis of the antioxidant activity of cassia fistula extracts. Int J Med Chem, 2012, 6.
19. Islam MS, Nagasaka R, Ohara K, et al (2011). Biological abilities of rice bran-derived antioxidant phytochemicals for medical therapy. Curr Top Med Chem, 11, 1847-53.
20. Jenab M, Thompson LU (2000). Phytic acid in wheat bran affects colon morphology, cell differentiation and apoptosis. Carcinogenesis, 21, 1547-52.
21. Kang MY, Kim SM, Rico CW, et al (2012). Hypolipidemic and antioxidative effects of rice bran and phytic acid in high fat-fed mice. Food Scie & Biotech, 21, 123-8.
22. Le NT, Richardson DR, (2004). Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. Blood, 104, 2967-75.
23. Lee HJ, Lee SA, Choi H (2005). Dietary administration of inositol and/or inositol-6-phosphate prevents chemically-induced rat hepatocarcinogenesis. Asian Pacific J Cancer Prev, 6, 41-7.
24. Li Y, Zhang S, Geng JX, Hu XY (2013). Curcumin inhibits human non-small cell lung cancer A549 cell proliferation through regulation of Bcl-2/Bax and cytochrome C. Asian Pac J Cancer Prev, 14, 4599-602.
25. Liang SX, Richardson DR (2003). The effect of potent iron chelators on the egulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1. Carcinogenesis, 24, 1601-14.
26. Liu Z, Cheng F, Zhang G (2005). Grain phytic acid content in japonica rice as affected by cultivar and environment and its relation to protein content. Food Chemistry, 89, 49-52.
27. Mehdi SJ, Ahmad A, Irshad M, et al (2011). Cytotoxic effect of carvacrol on human cervical cancer cells. Biol Med, 3, 307-12.
28. Norazalina S, Norhaizan M, Hairuszah I, et al (2010). Anticarcinogenic efficacy of phytic acid extracted from rice bran on azoxymethane-induced colon carcinogenesis in rats. Exper Tox Patho, 62, 259-68.
29. Norhaizan ME, Ng SK, Norashareena MS, et al (2011). Antioxidant and cytotoxicity effect of rice bran phytic acid as an anticancer agent on ovarian, breast and liver cancer cell lines. Malay J Nutr, 17, 367-75.
30. Nurul-Husna S, Norhaizan ME, Abdah MA, et al (2010). Rice bran phytic acid (IP6) induces growth inhibition, cell cycle arrest and apoptosis on human colorectal adenocarcinoma cells. J Med Plants Res, 4, 2283-9.
31. Richardson DR, Kalinowski DS, Lau S, et al (2009). Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim Biophys Acta, 1790, 702-17.
32. Rizvi MA, Irshad M, Hassadi GE, Younis SB (2009). Bioefficacies of cassia fistula: an Indian labrum. African J Pharm Pharmacol, 3, 287-92.
33. Saad N, Esa NM, Ithnin H (2013). Suppression of β-catenin and cyclooxygenase-2 expression and cell proliferation in azoxymethane-induced colonic cancer in rats by rice bran phytic acid (PA). Asian Pac J Cancer Prev, 14, 3093-9.
34. Saied IT, Shamsuddin AM (1990). Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line. Anticancer Res, 18, 1479-84.
35. Saletta F1, Suryo RY, Noulsri E, et al (2010). Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53. Mol Pharm, 77, 443-58.
36. Saw NK, Chow K, Rao PN, Kavanagh JP (2007). Effects of inositol hexaphosphate (Phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth. J Urology, 177, 2366-70.
37. Shinohara H, Fan D, Ozawa S, et al (2000). Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxin. Int J Oncol, 17, 643-51.
38. Slee EA, Adrain C, Martin SJ (2001). Executioner caspase-3,-6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem, 276, 7320-6.
39. Song H, Deng X, Yuan G, et al (2014). Expression of bcl-2 and p53 in Induction of esophageal cancer cell apoptosis by ECRG2 in combination with cisplatin. Asian Pac J Cancer Prev, 15, 1397-401.
40. Sun HJ, Meng LY, Shen Y, et al (2013). S-benzyl-cysteine-mediated cell cycle arrest and apoptosis involving activation of mitochondrial-dependent caspase cascade through the p53 pathway in human gastric cancer SGC-7901 cells. Asian Pac J Cancer Prev, 14, 6379-84.
41. Vucenik I, Tantivejkul K, Zhang ZS, et al (1997). IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Anticancer Res, 18, 4083-90.
42. Wang YJ, Niu XP, Yang L, Han Z, Ma YJ (2013). Effects of celecoxib on cycle kinetics of gastric cancer cells and protein expression of cytochrome C and caspase-9. Asian Pac J Cancer Prev, 14, 2343-7.
43. Xu Q, Kanthasamy AG, Reddy MB (2008). Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease. Toxicology, 245, 101-8.
44. Youle RJ, Strasser A (2008). The Bcl-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol, 9, 47-59.
45. Zajde A, Wilczok A, Weglarz L, et al (2013). Phytic acid inhibits lipid peroxidation in vitro. Bio Med Res Int, 2013, 6.
46. Zhang W, Gu H, Xi L, et al (2012). Preparation of phytic acid and its characteristics as copper Inhibitor. Energy Procedia, 17, 1641-7.